The news on a trial of an in-development Alzheimer's drug missed the point -- a potential treatment that could help millions. But smart investors read past the headline.
Read More...
[Source: MSN Money Latest Articles]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment